Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Yes on Issue 2 Campaign Files Third Elections Complaint Against Big Drug Companies

Ohio Taxpayers for Lower Drug Prices
Posted on: 31 Aug 17

The Yes on Issue 2 campaign today filed a third elections complaint with the Ohio Elections Commission against the big drug company campaign against lower drug prices, stating they failed to register their PAC before making expenditures in 2017. And they have never reported an in-kind contribution for the creation and use of the Vorys Report.

“There is an ongoing pattern of concealing contributions and spending by big drug companies. They can run and lie, but they cannot hide. Here is what we know: the Vorys Report issued in September, 2016 was bought and paid for by PhRMA. What we don’t know is how much that report is worth because the big drug company PAC failed to disclose it as a contribution as required by law,” said Dennis Willard, spokesperson for Yes on Issue 2. “The greedy drug companies have been running around the state using the Vorys Report in their misleading campaign, but they have never reported how much money they spent on the study or how much they paid consultants. They also have failed to identify which big drug companies paid for the report.”

Read the complaint here, and the supplement to the original complaint here.

“In addition, documents on the big drug company website indicates it was making expenditures months before registering as a PAC as required by law for reports by former Medicaid Director John McCarthy and former OBM Director Greg Browning. The reports from McCarthy and Browning were bought, paid for and given the big drug company stamp of approval months before the PAC was formed. Voters will see through the lies and vote yes on Issue 2 in November to lower drug prices and save tax dollars,” said Willard.

The complaint today follows two previous complaints filed with the Ohio Elections Commission. The first complaint, filed August 2, states that the opposition to Yes on Issue 2 failed to comply with Ohio’s campaign finance laws by creating an illegal scheme to hide the identity of donors and dollar amounts being used to campaign. The second complaint, filed August 10, demonstrated that the drug companies were making donations in 2016 with the purpose of influencing an election and failed to disclose the money, which is against Ohio law.

“In our previous complaints, we explain that greedy big drug companies spent millions of dollars starting in 2016 to influence the outcome of our Yes on Issue 2 campaign, and they did not report raising or spending a penny,” Willard said. “Two drug companies, Amgen and Biogen, told their shareholders they were contributing nearly $7.5 million to influence a ballot issue in Ohio in 2016, but the big drug company campaign never reported it.”

Background on Ohio Ballot Issue 2

The Yes on Issue 2 campaign is a broad-based, bi-partisan coalition. More than 200,000 Ohio voters signed petitions to put an amendment on the ballot in November that will lower drug prices for over 4 million Ohioans, including 164,000 children, save taxpayers $400 million annually, reduce healthcare costs for everyone and teach greedy drug companies and their CEOs a lesson.

You can learn more by visiting or following us on Facebook and Twitter.

Paid for by Ohio Taxpayers for Lower Drug Prices

View source version on

Business Wire

Last updated on: 31/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.